Research output per year
Research output per year
Personal profile
Research Biography
Welcome to my home page. I am a Research Fellow in the Precision Medicine Group at the College of Medicine and Public Health, Flinders University.
I am passionate about patient care and improving clinical outcomes of medicine use. My research aims to optimize disease treatment by understanding and predicting patient-specific treatment benefits and harms using state-of-the-art data and methods. In my work, I use clinical epidemiology and advanced modelling techniques that enable the development of clinical prediction models that allow personalised treatment decisions driving improved outcomes for patients. Notably, I incorporate artificial intelligence techniques into the development of such models.
Our research group is always interested in identifying and working with PhD and Honours students, and has several projects available. Students would need to obtain a scholarship that will cover their own living expenses and tuition fees, but we are more than happy to support qualified students in applying for available funding. Please contact me if you are interested.
Education/Academic qualification
PhD, University of South Australia
15 Feb 2014 → 19 Jun 2017
Award Date: 19 Jun 2017
Master of Science, University of Iowa
10 Aug 2009 → 16 Dec 2011
Award Date: 16 Dec 2011
Bachelor of Science, University of Jordan
1 Sep 2004 → 15 Jun 2009
Award Date: 15 Jun 2009
Fingerprint
Dive into the research topics where Ahmad Abuhelwa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A clinical scoring tool validated with machine learning for predicting severe hand–foot syndrome from sorafenib in hepatocellular carcinoma
Abuhelwa, A. Y., Badaoui, S., Yuen, H. Y., McKinnon, R. A., Ruanglertboon, W., Shankaran, K., Tuteja, A., Sorich, M. J. & Hopkins, A. M., Apr 2022, In: Cancer Chemotherapy and Pharmacology. 89, 4, p. 479-485 7 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile2 Downloads (Pure) -
Association between Patient-Reported Outcomes and Survival in Patients with Advanced Urothelial Carcinoma Treated with Atezolizumab
Tan, E., Abuhelwa, A. Y., Badaoui, S., Modi, N. D., Wiese, M. D., McKinnon, R. A., Sorich, M. J. & Hopkins, A. M., 11 Mar 2022, In: Bladder Cancer. 8, 1, p. 81-88 8 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Audit of Data Sharing by Pharmaceutical Companies for Anticancer Medicines Approved by the US Food and Drug Administration
Modi, N. D., Abuhelwa, A. Y., McKinnon, R. A., Boddy, A. V., Haseloff, M., Wiese, M. D., Hoffmann, T. C., Perakslis, E. D., Rowland, A., Sorich, M. J. & Hopkins, A. M., 28 Jul 2022, (E-pub ahead of print) In: JAMA Oncology. 7 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus) -
C-reactive protein provides superior prognostic accuracy than the IMDC risk model in renal cell carcinoma treated with Atezolizumab/Bevacizumab
Abuhelwa, A. Y., Bellmunt, J., Kichenadasse, G., McKinnon, R. A., Rowland, A., Sorich, M. J. & Hopkins, A. M., 1 Aug 2022, In: Frontiers in Oncology. 12, 7 p., 918993.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150
Hopkins, A. M., Kichenadasse, G., McKinnon, R. A., Abuhelwa, A. Y., Logan, J. M., Badaoui, S., Karapetis, C. S., Rowland, A. & Sorich, M. J., 1 Jan 2022, In: British Journal of Cancer. 126, 1, p. 42-47 6 p.Research output: Contribution to journal › Article › peer-review
12 Citations (Scopus)
Prizes
-
Academic Excellence Award in Postgraduate Research, Governor of SA
Abuhelwa, Ahmad (Recipient), 2017
Prize
-
-